SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-291997
Filing Date
2020-11-13
Accepted
2020-11-12 21:52:00
Documents
1
Effectiveness Date
2020-11-13

Document Format Files

Seq Description Document Type Size
1 DEFA14A d257316ddefa14a.htm DEFA14A 22112
  Complete submission text file 0001193125-20-291997.txt   23130
Mailing Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617
Business Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Filer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-38667 | Film No.: 201308969
SIC: 2834 Pharmaceutical Preparations